Insider Selling: Tenet Healthcare (NYSE:THC) Director Sells $652,075.00 in Stock

Tenet Healthcare Corporation (NYSE:THC) Director Tammy Romo sold 2,500 shares of the stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $260.83, for a total transaction of $652,075.00. Following the transaction, the director owned 28,284 shares in the company, valued at approximately $7,377,315.72. The trade was a 8.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Tammy Romo also recently made the following trade(s):

• On Thursday, August 6th, Tammy Romo sold 4,922 shares of Tenet Healthcare stock. The shares were sold at an average price of $264.15, for a total transaction of $1,300,146.30.

Tenet Healthcare Price Performance

NYSE THC opened at $266.87 on Thursday. The company has a market cap of $21.49 billion, a PE ratio of 10.29, a P/E/G ratio of 0.99 and a beta of 1.23. The firm’s 50 day moving average price is $205.96 and its 200-day moving average price is $202.93. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. Tenet Healthcare Corporation has a 52-week low of $157.58 and a 52-week high of $269.31.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The company had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. Tenet Healthcare’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Sell-side analysts forecast that Tenet Healthcare Corporation will post 21.07 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have issued reports on THC. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a research note on Monday, July 27th. Wells Fargo & Company raised their price target on shares of Tenet Healthcare from $231.00 to $281.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Piper Sandler set a $308.00 price objective on shares of Tenet Healthcare in a research note on Monday, July 27th. Mizuho set a $290.00 target price on shares of Tenet Healthcare in a research report on Monday. Finally, Morgan Stanley lifted their price target on shares of Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a report on Monday, July 27th. Seventeen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $272.25.

Hedge Funds Weigh In On Tenet Healthcare

Hedge funds have recently modified their holdings of the stock. Norges Bank acquired a new stake in Tenet Healthcare in the 4th quarter worth approximately $248,494,000. Wellington Management Group LLP raised its holdings in shares of Tenet Healthcare by 1,114.2% in the fourth quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock worth $225,706,000 after buying an additional 1,042,260 shares during the last quarter. Boston Partners lifted its stake in shares of Tenet Healthcare by 38.8% during the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after buying an additional 880,413 shares during the period. AQR Capital Management LLC increased its position in shares of Tenet Healthcare by 62.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after acquiring an additional 720,160 shares during the period. Finally, Alliancebernstein L.P. grew its stake in Tenet Healthcare by 375.7% during the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock valued at $139,085,000 after purchasing an additional 624,125 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.